Predictors of survival in Chinese patients with lupus nephritis

Z H Zheng1, L J Zhang, W X Liu

  • 1Department of Nephrology and Rheumatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Lupus
|April 20, 2012
PubMed

Insights

Predictors of survival in lupus nephritis (LN) were identified. Renal dysfunction and massive proteinuria are key risk factors, while hydroxychloroquine (HCQ) significantly improves survival rates in LN patients.

Area of Science:

  • Nephrology
  • Immunology
  • Clinical Medicine

Background:

  • Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus.
  • Understanding survival predictors is crucial for managing LN patients.

Purpose of the Study:

  • To identify predictors of survival in a cohort of Chinese patients with lupus nephritis.
  • To evaluate the impact of specific clinical factors and treatments on long-term outcomes.

Main Methods:

  • Retrospective analysis of 491 Chinese patients with lupus nephritis followed from 2003 to 2010.
  • Kaplan-Meier survival analysis, log-rank tests, and multivariate Cox regression modeling were employed.

Main Results:

  • Overall 5, 10, 15, and 20-year survival probabilities were 88%, 77%, 53%, and 45%, respectively.
  • Increased creatinine, massive proteinuria, and late-onset disease were associated with decreased survival.
  • Treatment with hydroxychloroquine (HCQ) and glucocorticoids was linked to improved survival.

Conclusions:

  • Elevated creatinine and massive proteinuria are independent risk factors for mortality in lupus nephritis.
  • Hydroxychloroquine (HCQ) demonstrates a significant protective effect, improving survival in LN patients.